The HLA locus contains novel foetal susceptibility alleles for congenital heart block with significant paternal influence

Journal of Internal Medicine

Volumn 275, Issue 6, 2014, Pages 640-651

  Meisgen, S ^a   Ostberg T ^a   Salomonsson, S ^a   Ding, B ^a   Eliasson, H ^a   Malarstig A ^a   Alfredsson, L ^a   Klareskog, L ^a   Hamsten, A ^a   Olsson, T ^a   Axelsson, T ^a   Gadler, F ^a   Jonzon, A ^a   Sonesson, S E ^a   Kockum, I ^a   Wahren Herlenius, M ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

04; Autoantibodies; Congenital heart block; HLA DRB1; MHC; Neonatal lupus erythematosus

Indexed keywords

HLA DRB1 ANTIGEN; RO ANTIBODY;

ADAPTIVE IMMUNITY; ADULT; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNE DISEASE; CASE CONTROL STUDY; CHROMOSOME 6; CONGENITAL HEART BLOCK; CONTROLLED STUDY; FATHER; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HLA SYSTEM; HLA TYPING; HUMAN; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; MOTHER; PARENTHOOD; PATERNAL INFLUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AUTOANTIBODIES; CONGENITAL HEART BLOCK; HLA-DRB1*04; MHC; NEONATAL LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, ANTINUCLEAR; CHILD; FAMILY HEALTH; FATHERS; FEMALE; GENE FREQUENCY; GENES, MHC CLASS II; GENETIC PREDISPOSITION TO DISEASE; HEART BLOCK; HLA-C ANTIGENS; HLA-DRB1 CHAINS; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SWEDEN;

EID: 84902075625     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12179     Document Type: Article

References (63)

1. Canti V, Castiglioni MT, Rosa S et al. Pregnancy outcomes in patients with systemic autoimmunity. Autoimmunity 2012; 45: 169-175.
2. Brucato A, Previtali E, Ramoni V, Ghidoni S. Arrhythmias presenting in neonatal lupus. Scand J Immunol 2010; 72: 198-204.
3. Salomonsson S, Strandberg L. Autoantibodies associated with congenital heart block. Scand J Immunol 2010; 72: 185-188.
4. Waltuck J, Buyon JP. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med 1994; 120: 544-551.
5. Press J, Uziel Y, Laxer RM, Luy L, Hamilton RM, Silverman ED. Long-term outcome of mothers of children with complete congenital heart block. Am J Med 1996; 100: 328-332.
6. Julkunen H, Eronen M. The rate of recurrence of isolated congenital heart block: a population-based study. Arthritis Rheum 2001; 44: 487-488.
7. Litsey SE, Noonan JA, O'Connor WN, Cottrill CM, Mitchell B. Maternal connective tissue disease and congenital heart block. Demonstration of immunoglobulin in cardiac tissue. N Engl J Med 1985; 312: 98-100.
8. Salomonsson S, Sonesson SE, Ottosson L et al. Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block. J Exp Med 2005; 201: 11-17.
9. Silverman ED, Buyon J, Laxer RM et al. Autoantibody response to the Ro/La particle may predict outcome in neonatal lupus erythematosus. Clin Exp Immunol 1995; 100: 499-505.
10. Buyon JP, Ben-Chetrit E, Karp S et al. Acquired congenital heart block. Pattern of maternal antibody response to biochemically defined antigens of the SSA/Ro-SSB/La system in neonatal lupus. J Clin Invest 1989; 84: 627-634.
11. Salomonsson S, Dorner T, Theander E, Bremme K, Larsson P, Wahren-Herlenius M. A serologic marker for fetal risk of congenital heart block. Arthritis Rheum 2002; 46: 1233-1241.
12. Strandberg L, Winqvist O, Sonesson SE et al. Antibodies to amino acid 200-239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block. Clin Exp Immunol 2008; 154: 30-37.
13. Brucato A, Gasparini M, Vignati G et al. Isolated congenital complete heart block: longterm outcome of children and immunogenetic study. J Rheumatol 1995; 22: 541-543.
14. Buyon JP, Hiebert R, Copel J et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998; 31: 1658-1666.
15. Solomon DG, Rupel A, Buyon JP. Birth order, gender and recurrence rate in autoantibody-associated congenital heart block: implications for pathogenesis and family counseling. Lupus 2003; 12: 646-647.
16. Strandberg L, Salomonsson S, Bremme K, Sonesson S, Wahren-Herlenius M. Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies. Lupus 2006; 15: 346-353.
17. Ambrosi A, Salomonsson S, Eliasson H et al. Development of heart block in children of SSA/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern. Ann Rheum Dis 2012; 71: 334-340.
18. Wahren-Herlenius M, Kuchroo VK. Gene-environment interaction in induction of autoimmunity. Semin Immunol 2011; 23: 65-66.
19. Strandberg LS, Ambrosi A, Jagodic M et al. Maternal MHC regulates generation of pathogenic antibodies and fetal MHC-encoded genes determine susceptibility in congenital heart block. J Immunol 2010; 185: 3574-3582.
20. Salomonsson S, Dzikaite V, Zeffer E et al. A population-based investigation of the autoantibody profile in mothers of children with atrioventricular block. Scand J Immunol 2011; 74: 511-517.
21. Skog A, Tingstrom J, Salomonsson S, Sonesson SE, Wahren-Herlenius M. Neurodevelopment in children with and without congenital heart block born to anti-Ro/SSA-positive mothers. Acta Paediatr 2013; 102: 40-46.
22. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
23. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-558.
24. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
25. Stolt P, Bengtsson C, Nordmark B et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis 2003; 62: 835-841.
26. Coronary Artery Disease (C4D) Genetics Consortium. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet 2011; 43: 339-44.
27. Plenge RM, Seielstad M, Padyukov L et al. TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study. N Engl J Med 2007; 357: 1199-1209.
28. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748.
29. Dudbridge F. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 2008; 66: 87-98.
30. Horton R, Wilming L, Rand V et al. Gene map of the extended human MHC. Nat Rev Genet 2004; 5: 889-899.
31. Haldane JB. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 1956; 20: 309-311.
32. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225-235.
33. Hedstrom AK, Sundqvist E, Baarnhielm M et al. Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. Brain 2011; 134: 653-664.
34. Link J, Lorentzen AR, Kockum I et al. Two HLA class I genes independently associated with multiple sclerosis. J Neuroimmunol 2010; 226: 172-176.
35. Ambrosi A, Dzikaite V, Park J et al. Anti-Ro52 monoclonal antibodies specific for amino acid 200-239, but not other Ro52 epitopes, induce congenital heart block in a rat model. Ann Rheum Dis 2012; 71: 448-454.
36. Alexander EL, McNicholl J, Watson RM, Bias W, Reichlin M, Provost TT. The immunogenetic relationship between anti-Ro(SS-A)/La(SS-B) antibody positive Sjogren's/lupus erythematosus overlap syndrome and the neonatal lupus syndrome. J Invest Dermatol 1989; 93: 751-756.
37. Miyagawa S, Shinohara K, Nakajima M et al. Polymorphisms of HLA class II genes and autoimmune responses to Ro/SS-A-La/SS-B among Japanese subjects. Arthritis Rheum 1998; 41: 927-934.
38. Miyagawa S, Shinohara K, Kidoguchi K et al. Neonatal lupus erythematosus: studies on HLA class II genes and autoantibody profiles in Japanese mothers. Autoimmunity 1997; 26: 95-101.
39. Liu XG, Zhan ZZ, Li D et al. Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk. Nat Immunol 2011; 12: 416-U71.
40. Ambrosi A, Wahren-Herlenius M. Congenital heart block: evidence for a pathogenic role of maternal autoantibodies. Arthritis Res Ther 2012; 14: 208.
41. Shiina T, Inoko H, Kulski JK. An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens 2004; 64: 631-649.
42. Clancy RM, Marion MC, Kaufman KM et al. Identification of candidate loci at 6p21 and 21q22 in a genome-wide association study of cardiac manifestations of neonatal lupus. Arthritis Rheum 2010; 62: 3415-3424.
43. Watson RM, Lane AT, Barnett NK, Bias WB, Arnett FC, Provost TT. Neonatal lupus erythematosus. A clinical, serological and immunogenetic study with review of the literature. Medicine (Baltimore) 1984; 63: 362-378.
44. Lee LA, Bias WB, Arnett FC Jr et al. Immunogenetics of the neonatal lupus syndrome. Ann Intern Med 1983; 99: 592-596.
45. Lockshin MD, Gibofsky A, Peebles CL, Gigli I, Fotino M, Hurwitz S. Neonatal lupus erythematosus with heart block: family study of a patient with anti-SS-A and SS-B antibodies. Arthritis Rheum 1983; 26: 210-213.
46. Miyagawa S. Neonatal lupus erythematosus: a review of the racial differences and similarities in clinical, serological and immunogenetic features of Japanese versus Caucasian patients. J Dermatol 2005; 32: 514-522.
47. Siren MK, Julkunen H, Kaaja R, Ekblad H, Koskimies S. Role of HLA in congenital heart block: susceptibility alleles in children. Lupus 1999; 8: 60-67.
48. Clancy RM, Kapur RP, Molad Y, Askanase AD, Buyon JP. Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart block. Arthritis Rheum 2004; 50: 173-182.
49. Holt PG, Jones CA. The development of the immune system during pregnancy and early life. Allergy 2000; 55: 688-697.
50. Alvarez D, Briassouli P, Clancy RM et al. A novel role of endothelin-1 in linking Toll-like receptor 7-mediated inflammation to fibrosis in congenital heart block. J Biol Chem 2011; 286: 30444-30454.
51. Ambrosi A, Salomonsson S, Eliasson H et al. Influence of season of birth and maternal age in the development of congenital heart block in Anti-Ro-SSA/La-SSB positive pregnancies. Scand J Immunol 2010; 72: 265.
52. Steere AC, Dwyer E, Winchester R. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N Engl J Med 1990; 323: 219-223.
53. Clancy RM, Backer CB, Yin X et al. Genetic association of cutaneous neonatal lupus with HLA class II and tumor necrosis factor alpha: implications for pathogenesis. Arthritis Rheum 2004; 50: 2598-2603.
54. Watson RM, Scheel JN, Petri M, Lee LA, Bias WB, McLean RH. Neonatal lupus erythematosus syndrome: analysis of C4 allotypes and C4 genes in 18 families. Medicine (Baltimore) 1992; 71: 84-95.
55. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30: 1205-1213.
56. Rioux JD, Goyette P, Vyse TJ et al. Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases. Proc Natl Acad Sci USA 2009; 106: 18680-18685.
57. Gregersen PK, Diamond B, Plenge RM. GWAS implicates a role for quantitative immune traits and threshold effects in risk for human autoimmune disorders. Curr Opin Immunol 2012; 24: 538-543.
58. Colombo G, Brucato A, Coluccio E et al. DNA typing of maternal HLA in congenital complete heart block: comparison with systemic lupus erythematosus and primary Sjogren's syndrome. Arthritis Rheum 1999; 42: 1757-1764.
59. Siren MK, Julkunen H, Kaaja R, Kurki P, Koskimies S. Role of HLA in congenital heart block: susceptibility alleles in mothers. Lupus 1999; 8: 52-59.
60. Arnaiz-Villena A, Vazquez-Rodriguez JJ, Vicario JL et al. Congenital heart block immunogenetics. Evidence of an additional role of HLA class III antigens and independence of Ro autoantibodies. Arthritis Rheum 1989; 32: 1421-1426.
61. Cooley HM, Keech CL, Melny BJ, Menahem S, Morahan G, Kay TW. Monozygotic twins discordant for congenital complete heart block. Arthritis Rheum 1997; 40: 381-384.
62. Kockum I, Wassmuth R, Holmberg E, Michelsen B, Lernmark A. Inheritance of MHC class II genes in IDDM studied in population-based affected and control families. Diabetologia 1994; 37: 1105-1112.
63. Ambrosi A, Dzikaite V, Strandberg L, Kuchroo VK, Wahren-Herlenius M. Anti-Ro52/p200 antibodies induce heart block in rodents upon transfer during gestation in a time- and dose-dependent manner. Scand J Immunol 2010; 72: 264-265.